Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Brimonidine 0.15% Purite, Dorzolamide 2%, and Brinzolamide 1% as Adjunctive Therapy to Prostaglandin Analogs

NCT00675207 is registered in ClinicalTrials.gov with Northwestern Ophthalmic Institute S.C. as lead sponsor.

NCT NCT00675207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00675207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Brimonidine 0.15% Purite, Dorzolamide 2%, and Brinzolamide 1% as Adjunctive Therapy to Prostaglandin Analogs
Lead sponsor
Northwestern Ophthalmic Institute S.C.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
July 31, 2007
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, primary open angle glaucoma